Results

Total Results: 981 records

Showing results for "supplement".

21. Archived: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
    January 10, 2017 - Population Women who are planning or capable of pregnancy Recommendation Take a daily supplement … Folic acid is usually given as a multivitamin, prenatal vitamin, or single supplement, and is also used … Folic acid is usually given as a multivitamin, prenatal vitamin, or single supplement. … a daily folic acid supplement, about half (14.6% of all women) were taking a supplement containing less … Folate: dietary supplement fact sheet.

22. Evidence Summary: Oral Health in Children and Adolescents Aged 5 to 17 Years: Screening and Preventive Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/oral-health-children-adolescents-screening-preventive-interventions
    November 07, 2023 - Cochrane Database of Systematic Reviews from inception to October 3, 2022 (eMethods 1 in the JAMA Supplement … abstracts, and full-text articles using predefined eligibility criteria (eMethods 2 in the JAMA   Supplement … as good, fair, or poor using predefined criteria developed by the USPSTF (eMethods 3 in the JAMA Supplement … between treatment vs placebo or no treatment in the DMFT or DFT index; see eMethods4 in the JAMA Supplement … were stratified by baseline age younger than 10 years or 10 years or older (eFigure 3 in the JAMA Supplement

23. Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary21/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling
    February 03, 2014 - Unadjusted relative risk for all-cause mortality at longest follow-up only, by supplement. … Unadjusted relative risk for cancer incidence at longest follow-up only, by supplement. … A “multivitamin” was the most frequently used supplement 2 . … Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). … . dietary supplement industry.

24. Archived: Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary21/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-february-2014
    February 03, 2014 - Unadjusted relative risk for all-cause mortality at longest follow-up only, by supplement. … Unadjusted relative risk for cancer incidence at longest follow-up only, by supplement. … A “multivitamin” was the most frequently used supplement 2 . … Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). … . dietary supplement industry.

25. Kprbmtobbwaemeqzzxwhcz (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/KprBMtobbwaeMEqZzxwHCz
    June 01, 2022 - USPSTF separately recommends that all persons who are planning or capable of pregnancy take a daily supplement … Nutrition Examination Survey data, more than half of surveyed US adults reported using at least 1 dietary supplement

26. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Service Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TkWNoq6KQb3SoZ54gscLCQ
    July 25, 2016 - the Cochrane Database of Systematic Reviews were searched from 2014 to August 2019 (eMethods 1 the Supplement … ),35-44,82 normalization of ALT levels (11 trials, n = 3875) (eFigure 7 in the Supplement),35-41,43,44,82 … (eTables 11-13 in the Supplement).45-51 Follow-up ranged from 2.7 to 8.9 years. … ),19,20,27,29,31 nausea (3 trials; RR, 0.80 [95% CI, 0.48 to 2.10]; I2 = 0%) (eFigure 11 in the Supplement … ),35,38,40,41,43,82 with- drawal due to adverse events (7 trials, n = 3223) (eFigure 15 in the Supplement

27. Evidence Summary: Primary Open-Angle Glaucoma: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/primary-open-angle-glaucoma-screening
    May 24, 2022 - of Systematic Reviews were searched from January 2011 to February 9, 2021 (eMethods 1 in the JAMA Supplement … , abstracts, and full-text articles using predefined eligibility criteria (eMethods 2 in the JAMA Supplement … the quality of each study as good, fair, or poor using predefined criteria (eMethods 3 in the JAMA Supplement … Details of the meta-analytic methods are provided in eMethods 4 in the JAMA Supplement. … 0.01 vs −0.03; P = .26) or vision-related quality of life after 1 year (eTables 1-2 in the JAMA Supplement

28. Evidence Summary: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/lipid-disorders-in-children-screening
    July 18, 2023 - interventions and 10 reported on the harms of supplement interventions. … These studies were small, of short duration, and had few contributing studies for any one supplement. … CARDIAC, 72 reported the prevalence of multifactorial dyslipidemia (eTables 5 and 6 in the JAMA Supplement … /dL and LDL-C reductions from −13.2 mg/dL to −45.9 mg/dL at 8 weeks (eFigures 6 and 7 in the JAMA Supplement … lipid levels (MD in LDL-C, −13.9 mg/dL [95% CI, −32.0 mg/dL to 4.2 mg/dL]) (eFigure 7 in the  JAMA  Supplement

29. Evidence Summary: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/chlamydia-and-gonorrhea-screening
    September 14, 2021 - Database of Systematic Reviews from January 1, 2014, through May 28, 2020 (eMethods 1 in the JAMA Supplement … and full-text articles for inclusion using predefined eligibility criteria (eMethods 2 in the JAMA Supplement … as good, fair, or poor using predefined criteria developed by the USPSTF (eMethods 3 in the  JAMA  Supplement … testing. 25 Two trials were rated good-quality[[25,32] and 2 fair-quality (eTable 1 in the  JAMA  Supplement … Three studies of site-specific testing for gonorrhea in females (eTable 8 in the  JAMA  Supplement) 23

30. Folic Acid Supplementation for the Prevention of Neural Tube Defects: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/7Y97fjKqmNzNorxTWUcyZK
    January 10, 2017 - Folic acid is usually given as a multivitamin, prena- tal vitamin, or single supplement. … Folic acid is usually given as a multivitamin, prenatal vitamin, or single supplement and is also used … Only 29% of all respondents reported taking a daily folic acid supplement.9 Among women who were taking … a daily folic acid supplement, about half (14.6% of all women) were taking a supplement containing less … Folate: dietary supplement fact sheet. https://ods.od.nih.gov/factsheets/Folate -HealthProfessional/.

31. Evidence Summary: Atrial Fibrillation: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/atrial-fibrillation-screening
    January 25, 2022 - To supplement systematic electronic searches (eMethods page 1 in the JAMA Supplement), reference lists … Detailed study quality assessments are provided in eTables 1 through 21 in the JAMA Supplement. … Findings are summarized in Figure 3 and in eTable 25 in the JAMA Supplement. … Study characteristics are detailed in eTables 32 and 33 in the JAMA Supplement. … Individual study results are detailed in eTable 34 in the JAMA Supplement.

32. Screening for Eating Disorders in Adolescents and Adults: Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Nw6T9w3t3yVcBzNar9vkfW
    March 15, 2022 - in the Supplement). … Individual study quality ratings are reported in eTables 4-7 in the Supplement. … Included trials focused on a variety of psychological inter- ventions (eTable 10 in the Supplement); … b Based on eFigure 2 in the Supplement, the 95% prediction region indicates results are inconsistent; … Design and field procedures in the US National Comorbidity Survey Replication Adolescent Supplement (

33. Primary Care Interventions to Prevent Child Maltreatment: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/DPq7_eawq-Ts6XLowaTaNA
    November 27, 2018 - abstracts, and full- text articles using prespecified inclusion criteria for each KQ (eTable 1 in the Supplement … a contextual question (eResults 2 in the Supplement). … Indi- vidual study quality ratings are reported in eTables 2 through 6 in the Supplement. … Table 1 summarizes study char- acteristics, and eTables 7 through 11 in the Supplement provide Figure … Death | Four trials of fair quality reported on the outcome of child death (eTable 34 in the Supplement

34. Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/k-btyK4W2-v9KnemTK8WDx
    September 14, 2021 - study as good, fair, or poor using predefined criteria devel- oped by the USPSTF (eMethods 3 in the Supplement … https://jama.com https://Supplement).16 https://accurate.17 https://review.17 https://report.15 https … https://jama.com https://participants.29 https://Supplement).34 https://partners.26 https://partner.26 … Three studies of site-specific testing for gonorrhea in females (eTable 8 in the Supplement)23,29,38 … https://jama.com https://Supplement).29 https://methodology.37 https://samples.29 https://Supplement)

35. Screening for Obstructive Sleep Apnea in Adults: Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rm4E5SooP2GnqJ_HVRA5M4
    January 01, 2017 - To supplement electronic searches, the reference lists of per- tinent articles were reviewed, as well … Individual study quality ratings are reported in eTables 4 through 12 in the Supplement. … Included were 76 RCTs: 56 trials evaluated CPAP (eTables 23 and 24 in the Supplement),53-112 10 trials … (eTable 26 in the Supplement),123-128 and 6 trials evaluated weight loss, diet, and exercise programs … Variables included in the models are detailed in eTable 33 in the Supplement.

36. Counseling and Behavioral Interventions for Healthy Weight and Weight Gain in Pregnancy: Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TkAWAdFHNkePeKEqUcH8AL
    May 25, 2021 - 30.4 [SD, 2.8] years), with study eligibility criteria ranging from 14 to 49 years (eTable 2 in the Supplement … in their second trimester and followed them up until at least 36 weeks’ gestation (eTable 4 in the Supplement … - tations included unclear reporting of randomization and allocation concealment (eMethods 2 in the Supplement … = 16.4%; absolute risk difference [ARD], −1.6% [95% CI, −2.5% to −0.7%]) (Table 1; eFigure 1 in the Supplement … (Table 1; eFigure 3 in the Supplement).

37. Final Evidence Summary: Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/bacterial-vaginosis-in-pregnancy-to-prevent-preterm-delivery-screening
    April 07, 2020 - To supplement systematic electronic searches (eMethods in the Supplement), reference lists of pertinent … Study characteristics are reported in eTable1 in the Supplement, and individual study methodological … quality is described in eTables 2 through 7 in the Supplement. … Detailed results are summarized in eTable 5 in the Supplement. … g The 95% prediction region covers more than one-third of the ROC space (eFigure 2 in the Supplement

38. Modeling Study: Breast Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/breast-cancer-screening
    April 30, 2024 - women over their lifetimes among 9 screening strategies stopping at age 74 (eTable 4 in the JAMA Supplement … thereafter; and annual starting at age 40) ( Figure 1 ; eFigures 1 and 2 and eTable 6 in the JAMA Supplement … ages 40 to 49 with biennial at ages 50 to 74, and annual at ages 40 to 74; eFigure 3 in the JAMA Supplement … 79 and increased among women with extremely dense breasts from 8.3 to 14.6 (eTable 12 in the JAMA Supplement … Efficiency frontier graphs for all models are shown in the JAMA Supplement.

39. Sacsr9Wnkmwkqw V9Kpdd (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/_saCsr9WNkmwKqW_V9kPDd
    April 01, 2014 - Forty-nine percent of adults used at least 1 dietary supplement between 2007 and 2010, and 32% reported … using a multivitamin–multimineral supplement See also: Print Summary for Patients. . . . . . . . . … Supplement use is more common in women and older adults than in men and younger adults (2). … Dietary supplement use among U.S. adults has increased since NHANES III (1988- 1994). … Dietary Supplement Industry. New York: Penton Media; 2011. 7. Dickinson A, Boyon N, Shao A.

40. Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/impaired-visual-acuity-screening-older-adults
    May 24, 2022 - of Systematic Reviews were searched from January 2015 to February 9, 2021 (eMethods 1 in the JAMA Supplement … , abstracts, and full-text articles using predefined eligibility criteria (eMethods 2 in the JAMA Supplement … the quality of each study as good, fair, or poor using predefined criteria (eMethods 3 in the JAMA Supplement … care–applicable settings vs no screening, usual care, or delayed screening (eTable 1 in the JAMA Supplement … conditions such as cataracts, refractive error, and AMD in older adults (eTables 3-4 in the JAMA Supplement